TruaceTracing the truth around AIFriday, August 28, 2026
TRV-2026-0920Version 1 · Certified

Written 2026-08-28 06:07:30 UTC · current record

Reason for this version

Certified into the record

Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-0920
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-08-28T06:07:30.631461Z
status: published
lens: trace
sector: health
headline: Association between body composition and recurrence in stage II-III colon cancer: a retrospective cohort study
dek: Colorectal Cancer (CRC) is a common cause of cancer death and prognostic factors are used to determine management. Patients with advanced disease often become cachectic, losing skeletal muscle mass and density, as well as subcutaneous fat. CT can be used to assess body composition by measuring skeletal muscle area, density and subcutaneous and visceral fat. We hypothesise that evidence of sarcopenia or myosteatosis at diagnosis is associated with an increased risk of cancer recurrence. Patients discussed at the…
gain_title: Using a machine learning model to measure CT body composition at L3 identified myosteatosis as an independent predictor of recurrence in stage II-III colon cancer.
problem_title: Patients with stage II-III colon cancer whose CT body composition showed myosteatosis via machine learning analysis had significantly lower 5-year recurrence-free survival.
trace_subject: machine-learning-derived myosteatosis as predictor of recurrence in stage II-III colon cancer
gain_reading: Using a machine learning model to measure CT body composition at L3 identified myosteatosis as an independent predictor of recurrence in stage II-III colon cancer.
gain_evidence: We analysed CT images at the level of the L3 transverse processes using pre-specified criteria with a machine learning model (Mosamatic) to determine body composition. | Myosteatosis was an independent predictor of recurrence on multivariate analysis (HR=1.62, p=0.026).
problem_reading: Patients with stage II-III colon cancer whose CT body composition showed myosteatosis via machine learning analysis had significantly lower 5-year recurrence-free survival.
problem_evidence: 71.7% of patients who developed recurrence had myosteatosis in comparison to 54.9% in the no recurrence group (p=0.001).
quick_read: Researchers applied a machine learning model called Mosamatic to routine CT staging scans from 615 patients with stage II-III colon cancer treated between 2015-2021 at one center to quantify skeletal muscle area, density, and fat. They found myosteatosis was more common in those who later recurred and was linked to worse recurrence-free survival at 1 and 5 years.

If validated, automated CT body composition could add a readily available prognostic marker to colon cancer management, helping stratify recurrence risk beyond traditional tumor factors. Uncertainty remains because the data are retrospective, single-institution, and rely on pre-defined literature cutoffs for myosteatosis and sarcopenia.
limitation: 
tag: Dual reading
key_points: 615 patients with stage II-III colon cancer who underwent surgery between 2015-2021 at a single institution were studied; 120 developed recurrence. | Skeletal muscle radiation attenuation was lower in recurrence group (34.3 HU vs 32.2 HU, p = 0.012) while Skeletal Muscle Index did not differ significantly. | 71.7% of patients who developed recurrence had myosteatosis versus 54.9% in no recurrence group (p=0.001), with no significant RFS difference for sarcopenia alone (p=0.17).
rundown: The study collated patients discussed at a colorectal cancer multidisciplinary team meeting from 2015-2021, including only stage II-III colon cancer after surgery and excluding rectal cancer and neoadjuvant therapy cases.

Body composition was derived from initial CT staging scans at L3 using Mosamatic, applying literature definitions for sarcopenia and myosteatosis, with recurrence-free survival as primary outcome and multivariate analysis showing HR=1.62 for myosteatosis.
sources:
- peer_reviewed | Clinical Nutrition ESPEN | https://doi.org/10.1016/j.clnesp.2026.105060 | 2026-08-26
prev: 0000000000000000000000000000000000000000000000000000000000000000
sha256
262955a4cbb875fb3a13ddac0d507e10a760a35d8b4614bb31a58d5f7660b34f
previous
0000000000000000000000000000000000000000000000000000000000000000
Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-0920 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.